Qian Chu
Clinical trials sponsored by Qian Chu, explained in plain language.
-
Immunotherapy combo shows promise in tough lung cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can help people with limited-stage small-cell lung cancer live longer without the cancer growing. About 100 adults with this aggressive lung cancer will receive durvalumab plu…
Phase: PHASE2 • Sponsor: Qian Chu • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
AI model aims to predict lung cancer therapy outcomes
Knowledge-focused Recruiting nowThis study is testing whether a computer model that looks at many types of patient data can predict how well pre-surgery treatment works for non-small cell lung cancer. Researchers will study 500 people receiving chemo-immunotherapy before surgery. The goal is to improve treatmen…
Sponsor: Qian Chu • Aim: Knowledge-focused
Last updated May 26, 2026 09:03 UTC